Sign In
Buy CSTL
$24.69
-0.795 (-3.12%)
At Close: Jul 24, 2026
Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Tops Revenue Estimates
06:51pm, Thursday, 02'nd May 2024
Castle Biosciences, Inc. (CSTL) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.37. This compares to loss of $1.10 per share a year ago.
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CSTL--Castle Biosciences announced its support of key skin cancer advocacy events and initiatives throughout May in honor of Skin Cancer Awareness Month.
Castle Biosciences to Release First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 2, 2024
07:00am, Thursday, 11'th Apr 2024
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CastleBiosciences--Castle will release its financial results for the first quarter ended March 31, 2024, after the close of market on Thursday, May 2, 20
Castle Biosciences Celebrates Esophageal Cancer Awareness Month through Advocacy and Educational Collaborations
05:00pm, Wednesday, 10'th Apr 2024
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CastleBiosciences--Castle recognizes the importance of Esophageal Cancer Awareness Month and is providing its support of key programs and initiatives thr
Castle Biosciences' Chief Financial Officer Frank Stokes Recognized as a Top CFO of Houston for Second Consecutive Year
07:00am, Wednesday, 10'th Apr 2024
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CastleBiosciences--For the second year in a row, Castle's chief financial officer, Frank Stokes, has been selected as a Top 25 CFO of Houston by TOP CFOs
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CSTL--Castle will share new data on its DecisionDx-Melanoma and DecisionDx-SCC tests at the 20th European Association of Dermato-Oncology (EADO) Congress
Castle Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference
07:00am, Tuesday, 02'nd Apr 2024
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CastleBiosciences--Castle's executive management will present a company overview at the 23rd Annual Needham Virtual Healthcare Conference Tuesday, 4/9/24
Castle Biosciences Announces Updates to its Board of Directors
05:00pm, Wednesday, 27'th Mar 2024
FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle today announced that Rodney Cotton has been appointed to its board of directors, effective immediately.
Castle Biosciences Earns a Top Workplaces USA Award for the Third Consecutive Year
07:00am, Monday, 25'th Mar 2024
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CastleBiosciences--Castle announced it has received a Top Workplaces USA award for the third consecutive year.
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CSTL--Castle announced new data highlighting the performance of its DecisionDx-Melanoma test in predicting risk of SLN positivity in patients with melano
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #40GEP--Expert consensus article in JCAD recommends framework including DecisionDx-SCC test for adjuvant radiation therapy decision-making in SCC patients
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CastleBiosciences--Castle announces new data highlighting its IDgenetix PGx test in guiding medication recommendations for patients 65+ with mental healt
Castle Biosciences to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum
07:00am, Tuesday, 12'th Mar 2024
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CastleBiosciences--Castle Biosciences' executive management will present a company overview at the KeyBanc Capital Markets Virtual Life Sciences & MedTec
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #AAD2024--Castle Biosciences announces it will share data across its dermatologic portfolio of gene expression profile tests at the 2024 AAD Annual Meetin
Castle Biosciences, Inc. (CSTL) Q4 2023 Earnings Call Transcript
09:30pm, Wednesday, 28'th Feb 2024
Castle Biosciences, Inc. (CSTL) Q4 2023 Earnings Call Transcript
